Drugs / SR-fampridine
last change Jan 2015 re-read 3 minutes ago

SR-fampridine

Developed for
multiple sclerosis
Investigated by
Biogen · Region of Southern Denmark · University of Southern Denmark

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02143167 May 2014 → Jan 2015 multiple sclerosis University of Southern Denmark Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SR-fampridine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02143167 ↗